glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
TRAZODONE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
TRAZODONE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
TRAZODONE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
VALACYCLOVIR |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
VALACYCLOVIR |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
adenosine A1 receptor |
ISOEUGENOL |
Adenosine A1 |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
ISOEUGENOL |
GABAA, Chloride Channel, TBOB |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 |
ISOTRETINOIN |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
ISOTRETINOIN |
Cyclooxygenase COX-2 |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
MYCOPHENOLATE MOFETIL |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
MYCOPHENOLATE MOFETIL |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA1 (alpha 1) |
MOSAPRIDE |
Glutamate, AMPA |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA2 |
MOSAPRIDE |
Glutamate, AMPA |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, AMPA3 (alpha 3) |
MOSAPRIDE |
Glutamate, AMPA |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor subunit 4c |
MOSAPRIDE |
Glutamate, AMPA |
-16% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
ISOTRETINOIN |
Protein Serine/Threonine Kinase PKCalpha |
-16% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
ISOTRETINOIN |
Protein Serine/Threonine Kinase PKCalpha |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 1 |
VALACYCLOVIR |
Adrenergic beta1 |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic, beta-1-, receptor |
VALACYCLOVIR |
Adrenergic beta1 |
-16% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y1 |
MYCOPHENOLATE MOFETIL |
Neuropeptide Y1 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2B |
GLYCOLIC ACID |
Serotonin 5-HT2B |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 1 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, pi |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
AT hook, DNA binding motif, containing 1 (DBSS) |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, theta |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, gamma 2 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
EPERISONE |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
MYCOPHENOLIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
MYCOPHENOLIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
MYCOPHENOLIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
MYCOPHENOLIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
MYCOPHENOLIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
Cytochrome P450, subfamily IIC (mephenytoin 4-hydroxylase) |
TERAZOSIN |
CYP450-2C9 Inhibition |
-16% |
NoneNone |
NoneNone |
View
|
cytochrome P450, family 2, subfamily C, polypeptide 9 |
TERAZOSIN |
CYP450-2C9 Inhibition |
-16% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
(RS)-AMPA |
Vasoactive Intestinal Peptide VIP1 |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
DIHYDROERGOTAMINE |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
monoamine oxidase A |
DIHYDROERGOTAMINE |
Monoamine Oxidase MAOA |
-16% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
PREGNENOLONE-16ALPHA-CARBONITRILE |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
calcitonin receptor |
DACARBAZINE |
Calcitonin |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
DICYCLOMINE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
DICYCLOMINE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
DICYCLOMINE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
DICYCLOMINE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
DICYCLOMINE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
DICYCLOMINE |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
matrix metallopeptidase 9 |
DIFLORASONE DIACETATE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-16% |
NoneNone |
NoneNone |
View
|
matrix metalloproteinase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) |
DIFLORASONE DIACETATE |
Protease, Matrix Metalloprotease-9 (MMP-9) |
-16% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 4 polypeptide |
NIFEDIPINE |
ATPase, Na+/K+ |
-16% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 3 polypeptide |
NIFEDIPINE |
ATPase, Na+/K+ |
-16% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 2 polypeptide |
NIFEDIPINE |
ATPase, Na+/K+ |
-16% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
NIFEDIPINE |
ATPase, Na+/K+ |
-16% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 1 polypeptide |
NIFEDIPINE |
ATPase, Na+/K+ |
-16% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 3 polypeptide |
NIFEDIPINE |
ATPase, Na+/K+ |
-16% |
NoneNone |
NoneNone |
View
|
ATPase, Na+/K+ transporting, beta 2 polypeptide |
NIFEDIPINE |
ATPase, Na+/K+ |
-16% |
NoneNone |
NoneNone |
View
|
ATPase, (Na+)/K+ transporting, beta 4 polypeptide |
NIFEDIPINE |
ATPase, Na+/K+ |
-16% |
NoneNone |
NoneNone |
View
|
chemokine (C-C motif) receptor 4 |
CILOSTAMIDE |
Chemokine CCR4 |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 1 |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 4 subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 3 subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, beta 2 subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, alpha 1F subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1D subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, L type, alpha 1C subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
DIFLUNISAL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 2 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, alpha 1 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid A receptor, delta |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 |
ZOMEPIRAC |
GABAA, Agonist Site |
-16% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
AMIKACIN |
Vascular Endothelinal Growth Factor (VEGF) |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 1 |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel associated protein 2 |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IX, alpha |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VII, alpha |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
amiloride-sensitive cation channel 5, intestinal |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, beta |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type VIII, alpha polypeptide |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type XI, alpha |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 10, alpha polypeptide |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha polypeptide |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha polypeptide |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 alpha |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 gamma |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, nonvoltage-gated 1 beta |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type 2, alpha 1 polypeptide |
RAMIPRIL |
Sodium Channel, Site 2 |
-15% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
DIPHENHYDRAMINE |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 3 |
TRIHEXYPHENIDYL |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 1 subunit |
TRIHEXYPHENIDYL |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, beta subunit |
TRIHEXYPHENIDYL |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
glycine receptor, alpha 2 subunit |
TRIHEXYPHENIDYL |
Glycine, Strychnine-Sensitive |
-16% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
TRIHEXYPHENIDYL |
Vascular Endothelinal Growth Factor (VEGF) |
-16% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
TRIHEXYPHENIDYL |
Vascular Endothelinal Growth Factor (VEGF) |
-16% |
NoneNone |
NoneNone |
View
|
Cytochrom P450-1A2 monooxygenase |
ANDROSTERONE |
CYP450-1A2 Inhibition |
-16% |
NoneNone |
NoneNone |
View
|
endothelin receptor type A |
FLUCYTOSINE |
Endothelin ETA |
-16% |
NoneNone |
NoneNone |
View
|
FMS-like tyrosine kinase 1 |
CHLORTETRACYCLINE |
Vascular Endothelinal Growth Factor (VEGF) |
-16% |
NoneNone |
NoneNone |
View
|
fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
CHLORTETRACYCLINE |
Vascular Endothelinal Growth Factor (VEGF) |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
FLUCYTOSINE |
Serotonin 5-HT2C |
-16% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
GERANIOL |
Neuropeptide Y2 |
-16% |
NoneNone |
NoneNone |
View
|
neuropeptide Y receptor Y2 |
GERANIOL |
Neuropeptide Y2 |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
UBENIMEX |
Adrenergic beta2 |
-16% |
NoneNone |
NoneNone |
View
|
interleukin 8 receptor, alpha |
DOXAZOSIN |
Chemokine CXCR1(IL-8A) |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
DROPERIDOL |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
leukotriene C4 synthase |
DROPERIDOL |
Leukotriene C4 Synthetase |
-16% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
DROPERIDOL |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 9 |
DROPERIDOL |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 8 |
DROPERIDOL |
Potassium Channel [KATP] |
-16% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
UBENIMEX |
Protein Tyrosine Kinase, HER2 Receptor |
-16% |
NoneNone |
NoneNone |
View
|
v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
UBENIMEX |
Protein Tyrosine Kinase, HER2 Receptor |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3a |
SULFASALAZINE |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 3b |
SULFASALAZINE |
Serotonin 5-HT3 |
-16% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 1 |
DIPHENHYDRAMINE |
Protein Serine/Threonine Kinase, ERK2 |
-16% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 1 |
DIPHENHYDRAMINE |
Protein Serine/Threonine Kinase, ERK2 |
-16% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
CIPROFLOXACIN |
Protein Serine/Threonine Kinase PKCalpha |
-16% |
NoneNone |
NoneNone |
View
|
protein kinase C, alpha |
CIPROFLOXACIN |
Protein Serine/Threonine Kinase PKCalpha |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 8 |
CHOLECALCIFEROL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 7 |
CHOLECALCIFEROL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 6 |
CHOLECALCIFEROL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 5 |
CHOLECALCIFEROL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 4 |
CHOLECALCIFEROL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 3 |
CHOLECALCIFEROL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
calcium channel, voltage-dependent, gamma subunit 2 |
CHOLECALCIFEROL |
Calcium Channel Type L, Phenylalkylamine |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, beta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type IV, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type III, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, beta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type II, alpha 2 |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, beta |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
sodium channel, voltage-gated, type I, alpha |
PHENYLHYDRAZINE |
Sodium Channel, Site 2 |
-16% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
POLYVINYLPYRROLIDONE |
Vasoactive Intestinal Peptide VIP1 |
-16% |
NoneNone |
NoneNone |
View
|
dopamine receptor D4 |
POLYVINYLPYRROLIDONE |
Dopamine D4.2 |
-16% |
NoneNone |
NoneNone |
View
|
5-hydroxytryptamine (serotonin) receptor 2C |
PHENYTOIN |
Serotonin 5-HT2C |
-16% |
NoneNone |
NoneNone |
View
|
adenosine A2a receptor |
ALLOPURINOL |
Adenosine A2A |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
ALENDRONIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
ALENDRONIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
ALENDRONIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
ALENDRONIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
ALENDRONIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
ALENDRONIC ACID |
Glutamate, NMDA, Agonism |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 1 |
ACECLOFENAC |
Muscarinic M1 |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
ACECLOFENAC |
Muscarinic M5 |
-16% |
NoneNone |
NoneNone |
View
|
adrenergic receptor, beta 2 |
NANDROLONE |
Adrenergic beta2 |
-16% |
NoneNone |
NoneNone |
View
|
cholinergic receptor, muscarinic 5 |
NANDROLONE |
Muscarinic M5 |
-16% |
NoneNone |
NoneNone |
View
|
bradykinin receptor, beta 2 |
PAPAVERINE |
Bradykinin B2 |
-16% |
NoneNone |
NoneNone |
View
|
bradykinin receptor B2 |
PAPAVERINE |
Bradykinin B2 |
-16% |
NoneNone |
NoneNone |
View
|
mitogen activated protein kinase 14 |
RESERPINE |
Protein Serine/Threonine Kinase, p38alpha |
-16% |
NoneNone |
NoneNone |
View
|
mitogen-activated protein kinase 14 |
RESERPINE |
Protein Serine/Threonine Kinase, p38alpha |
-16% |
NoneNone |
NoneNone |
View
|
DNA encoding receptor of vasoactive intestinal polypeptide |
OLANZAPINE |
Vasoactive Intestinal Peptide VIP1 |
-16% |
NoneNone |
NoneNone |
View
|
angiotensin II receptor, type 2 |
NORETHINDRONE |
Angiotensin AT2 |
-16% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
NICOTINE |
Leukotriene D4 |
-16% |
NoneNone |
NoneNone |
View
|
cysteinyl leukotriene receptor 1 |
NICOTINE |
Leukotriene D4 |
-16% |
NoneNone |
NoneNone |
View
|
Protein-tyrosine kinase, Fyn |
ALPHA-CYCLODEXTRIN |
Protein Tyrosine Kinase, Fyn |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2D |
OXAPROZIN |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, NMDA2C |
OXAPROZIN |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
OXAPROZIN |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
OXAPROZIN |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
N-methyl-D-aspartate receptor 1 (Grin1) gene, exons 1 through 6 and partial cds; alternatively spliced (Rn.) |
OXAPROZIN |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
glutamate receptor, ionotropic, N-methyl-D-aspartate 3B |
OXAPROZIN |
Glutamate, NMDA, Phencyclidine |
-16% |
NoneNone |
NoneNone |
View
|
solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
OXYMETAZOLINE |
Dopamine Transporter |
-16% |
NoneNone |
NoneNone |
View
|
insulin receptor |
OXYQUINOLINE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|
insulin receptor |
OXYQUINOLINE |
Insulin |
-16% |
NoneNone |
NoneNone |
View
|